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Abstract: The K free light chain (K) index has been suggested as a reliable marker of intrathecal
synthesis, despite the 2017 McDonald criteria for multiple sclerosis (MS) suggesting to “interpret with
caution positive immunoglobulin G (IgG) index when testing for oligoclonal bands (OB) is negative
or not performed”. The aim of this study was to compare the performance of K and IgG indexes for
MS diagnosis and OB detection in a cohort of Italian patients. We enrolled 385 patients (127 MS,
258 non-MS) who had cerebrospinal fluid (CSF) analysis, including isoelectric focusing (IEF), to detect
OB in the diagnostic work-up. Albumin, IgG and free light chains were measured by nephelometry
and used to calculate IgG and K indexes. Although the two markers were highly related (r = 0.75,
r2 = 0.55, p < 0.0001), the K index showed greater sensitivity and negative predictive value (versus the
IgG index) for OB detection (97% versus 48% and 97% versus 71%) and MS diagnosis (96% versus
50% and 98% versus 78%). These results support K index (and not IgG index) as a first-line marker
for MS, followed by IEF, according to a sequential testing approach in CSF analysis.
Keywords: cerebrospinal fluid; diagnosis; immunoglobulins
1. Introduction
Multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous
system, is diagnosed according to McDonald criteria with the exclusion of other differentials [1].
Since the first version of the criteria, cerebrospinal fluid (CSF) analysis has been included to evaluate
intrathecal antibody synthesis as a supportive finding [2]. The 2017 revision upgraded the role of
CSF analysis to diagnose MS in subjects who presented a single episode, instead of a second clinical
event and/or increased lesion load [3]. The gold standard for CSF analysis is isoelectric focusing (IEF)
to detect CSF oligoclonal bands (OB) of immunoglobulin (Ig) G. Historically, intrathecal synthesis
of IgG has been detected as an elevated immunoglobulin G (IgG) or Link index, calculated as the
ratio of CSF/serum IgG to CSF/serum albumin [4]. Recently, measures of free light chains (FLC) by
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nephelometry have been proposed as an alternative method to IgG index and OB detection by IEF [5].
Despite the role of lambda (λ) FLC remains controversial, there is robust evidence for kappa (K)
FLC [6,7]. The rationale of this biochemical approach is to detect intrathecal KFLC with high sensitivity
as evidence of B-cell activity within the CSF. As for IgG, the ratio of CSF/serum KFLC may be corrected
by the ratio of CSF/serum albumin to obtain the KFLC (or K) index [6]. In this context, the K index is
proposed as a highly sensitive first-line test for intrathecal synthesis of Ig followed by IEF, in a sequential
approach [8] similarly to thyroid hormones testing [9].
It must be underlined that the 2017 McDonald criteria includes the recommendation to “use caution
with positive IgG index when testing for OB is negative or not performed” [3], and discussion of
the actual role of KFLC versus OB testing has not reach a definite agreement to date [10]. However,
a sequential method has been recently considered as reasonable [8–11]. The aims of this study were to
confirm the role of the K index in CSF screening for MS and compare its performances to that of the
IgG index and OB in a large cohort of Italian patients.
2. Experimental Section
A total of 385 patients was consecutively enrolled in the study and underwent lumbar puncture (LP)
in their diagnostic work-up for CSF biochemistry and IEF (according to the requesting neurologist)
from January 2014 to January 2018, which included those patients described by Crespi [8]. The mean
age of patients was 48 years (standard deviation, SD ± 18). Diagnosis was prospectively collected
by a different neurologist and compared with the initial clinical suspicion. Of the 385 patients,
127 (33%) were diagnosed with MS according to the 2017 McDonald criteria [3], 117 (30%) with
other neurological inflammatory diseases (ID: inflammatory neuropathies, acute demyelinating
encephalomyelitis, systemic autoimmune disorders with central nervous system involvement) and
141 (37%) with non-inflammatory neurological diseases (NID: amyotrophic lateral sclerosis, dementia,
non-inflammatory neuropathies, tumors). Patients signed an informed consent form for both diagnostic
and research purposes at the time of the LP. The study was approved by the ethical committee of
the University Hospital of Novara (reference no. CE1804). This study did not include identifiable
patient data.
The OB detection was achieved by isoelectric focusing and immunofixation (Hydragel 9 CSF
Isofocusing; Sebia, Bagno a Ripoli, FI, Italy) on an agarose electrophoresis system (Sebia Hydrasys).
Two independent operators, blind to the diagnosis, evaluated the results and classified the OB pattern
into five different types: (1) no bands in CSF and serum; (2) oligoclonal IgG in CSF but not in serum;
(3) IgG bands in both CSF and serum, with additional bands in CSF; (4) identical oligoclonal bands in
CSF and serum; (5) monoclonal IgG pattern in both CSF and serum. Types 2 and 3 are associated with
intrathecal immunoglobulin synthesis [12]. Serum and CSF albumin, Ig, λ and KFLC were measured by
nephelometric assays using BN II System (Siemens Healthcare Diagnostics Products GmbH, Marburg,
Germany) according to methods used in a previous paper [8]. We calculated IgG (or Link) and KFCL
(or K) indexes as well as Reiber-modified parameters (IgG loc and K loc) according to published
formulas [10,13].
Sensitivity (%), specificity (%), likelihood ratio for positive test, likelihood ratio for negative
test and positive and negative predictive values (%) were measured using the Bayesian calculator
developed by SIPMEL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) [14].
Statistical analyses were performed using VassarStats (website for statistical computation) [15].
The t test for two independent samples was used for group comparison with equal and/or unequal
sample variances. The difference between three or more samples was calculated using one-way
ANOVA. Qualitative variables, e.g., the frequency of KFLC intrathecal synthesis among the disease
groups, were compared with χ2 test. Spearman’s coefficient was used for correlation analysis.
Receiver Operating Characteristic curve analysis was performed using XLSTAT statistical package
(Addinsoft Inc., Long Island City, NY, USA).
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3. Results
3.1. Markers of Intrathecal Synthesis in MS
The 127 MS patients had a median K index of 72.9 ± a SD of 87.9 that was significantly higher
than that displayed by the other 258 patients (12.7 ± 48.9; p < 0.0001), including both ID (23.5 ± 70.7;
p < 0.0001) and NID (3.8 ± 8.4; p < 0.0001), as shown in Figure 1 and Table 1. The K index was >5 in
96.1% MS, 19.4% non-MS, 33.3% ID, and 7.8% NID patients.
The IgG index values were higher in MS (0.86 ± 0.5) than in the other patients (0.50 ± 0.23;
p < 0.0001). The IgG index was >0.7 in 59.1% MS, 15.1% non-MS, 17.9% ID, and 12.8% NID patients.
OB types 2 and 3 were detected in 123 (96.8%) MS patients and 44 (17%) patients with other
neurological disorders (35 ID and nine NID patients).
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< 0.001) whereas the IgG index was not able to differentiate ID from NID (the Tukey test was not significant). In 
addition, a correlation was confirmed between IgG and K indexes in all patients (n = 385: r = 0.75, r2 = 0.55, p < 
0.0001) and in each group (Supplementary material Table S1).  
3.2. Comparisons and Diagnostic Performances of K and IgG Indexes 
To compare the ability of the K and IgG indexes to predict intrathecal synthesis, their correlation with OB 
and MS diagnosis was analyzed by receiver operating characteristic (ROC) analysis. The K index showed a 
Figure 1. Kappa (K) (left) and immunoglobulin G (IgG) (right) indexes in patients with multiple
sclerosis (MS) in group 1, inflammatory diseases (ID) in group 2 and non-inflammatory diseases (NID)
in group 3.
Table 1. Prevalence of elevated K and IgG indexes a oligoclonal b nds (OB) types 2 and 3 among
patients with multiple sclerosis (MS), inflammatory diseases (ID) and non-inflammatory diseases (NID).
Parameters MS (n: 127) Non-MS (n: 258) ID (n: 117) NID (n: 141)
IgG index > 0.7 (n, %) 75/127 (59.1%) 39/258 (15.1%) 21/117 (17.9%) 18/141 (12.8%)
K index > 5 (n, %) 122/127 (96.1%) 50/258 (19.4%) 39/117 (33.3%) 11/141 (7.8%)
OB (n, %) 123/127 (96.8%) 44/258 (17%) 35/117 (29.9%) 9/141 (6.4%)
MS: multiple sclerosis; ID: inflammatory diseases; NID: non-inflammatory diseases, OB: oligoclonal bands;
n: number.
Analysis of MS, ID and NID patients showed that the K index was different in the three groups
(ANOVA p < 0.001) whereas the IgG index was not able to differentiate ID from NID (the Tukey test
was not sig ificant). In addition, a corr lation was confirmed between IgG and K indexes in all patients
(n = 385: r = 0.75, r2 = 0.55, p < 0.0001) and in each group (Supplementary material Table S1).
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3.2. Comparisons and Diagnostic Performances of K and IgG Indexes
To compare the ability of the K and IgG indexes to predict intrathecal synthesis, their correlation
with OB and MS diagnosis was analyzed by receiver operating characteristic (ROC) analysis. The K
index showed a better area under curve (AUC) (0.981) than the IgG index (0.778) to predict OB
(Figure 2A) and to diagnose MS (AUC of the K index 0.949 vs. AUC of the IgG index 0.789, Figure 2B).
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Figure 2. Receiver operating haracteristic (ROC) analysis for K and IgG ind xes in pre icting OB
detection and diagnosing multiple sclerosis. (A) K index or IgG index vs. isoelectric focusing (IEF);
(B) K index or IgG index vs. MS.
In panel A, ROC analysi was performed for OB (types 2 and 3 by IEF) versus the absence of
OB (types 1, 4 and 5); AUC was 0.778 for IgG (open symb ls) an 0.981 for K index (closed symbols).
In panel B, ROC analysis was performed for MS patients versus non-MS patients; AUC was 0.789 for
IgG (open symbols) and 0.949 for K index (closed symbols).
The diagnostic parameters of both indexes in predicting OB and diagnosing MS were then
considered. In detecting OB, the K index (cut off value 5) showed a significantly better sensitivity,
likelihood ratio for a positive test, positive and negative predictive values and efficacy compared to the
IgG index (cut off value 0.7) [4]. By contrast, the specificity was similar for both indexes. In diagnosing
MS, the K index exhibited higher sensitivity, negative predictive value and efficiency than the IgG
index (Tables 2 and 3).
Table 2. Diagnostic performances of IgG index, IgG loc, K index and K loc for OB detection by IEF.
OB Detection
IgG Index IgG loc K Index K loc
Sensitivity (%) 48.0 (41.2–54.9) 47.6 (40.6–54.7) 96.5 (93.0–98.3) 95.8 (91.8–97.8)
Specificity (%) 93.8 (90.3–96.1) 95.5 (92.0–97.4) 89.8 (85.7–92.9) 93.3 (89.4–95.8)
Likelihood ratio for a positive test 7.8 (4.8–12.6) 10.5 (5.8–19.0) 9.48 (6.7–13.5) 14.2 (8.8 22.
Likelihood ratio for a negative test 0.6 (0.5–0.6) 0.6 (0.5–0.6) 0.04 (0.02–0.08) 0.04 (0.02–0.09)
Positive predictive value (%) 85.1 (77.4– 0.5) 89.1 (81.5–93.8) 7 4 (82 5–91.2) . ( .2–94.9)
Negative predictive value (%) 71.1 (66.2–75.5) 70.0 (64.8–74.7) 97.2 (94.4–98.7) 96.5 (93.3–98.2)
Efficiency (%) 74.4 (70.3–78.1) 74.5 (70.2–78.4) 92.7 (89.9–94.7) 94.4 (91.8–96.2)
Pre-test probability (prevalence) (%) 42.3 (37.9–46.8) 43.8 (39.2–48.6) 42.3 (37.9–48.8) 44.3 (39.6–49.0)
Pre-test odds 0.7 (0.6–0.9) 0.8 (0.7–0.9) 0.7 (0.6–0.9) 0.8 (0.7–0.96)
Post-test odds 5.7 (2.9–11.1) 8.2 (3.7–17.9) 6.9 (4.1–11.9) 11.3 (5.8–22.0)
Post-test probability (%) 85.1 (74.6–91.7) 89.1 (78.8–94.7) 87.4 (80.3–92.2) 91.9 (85.3–95.7)
Number needed to diagnose (NND) 2.4 (3.2–2.0) 2.3 (3.2–1.9) 1.2 (1.3–1.1) 1.1 (1.2–1.1
The analysis was performed for OB (types 2 and 3 by IEF) versus absence of OB (types 1, 4 and 5 by IEF); data are
reported with their 95% confidence intervals.
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Table 3. Diagnostic performances of IgG index, IgG loc, K index and K loc for MS diagnosis.
MS Diagnosis
IgG Index IgG loc K Index KFLC loc
Sensitivity (%) 49.6 (42.5–56.7) 51.3 (42.4–60.1) 96.1 (90.8–98.5) 95.8 (90.5–98.2)
Specificity (%) 88.5 (84.2–92.7) 90.7 (86.6–93.7) 77.9 (72.0–83.7) 80.7 (75.5–85.0)
Likelihood ratio for a positive test 4.3 (3.1–7.0) 5.5 (3.6–8.4) 4.4 (3.1–5.9) 5.0 (3.9–6.4)
Likelihood ratio for a negative test 0.6 (0.5–0.7) 0.5 (0.4–0.7) 0.05 (0.02–0.11) 0.05 (0.02–0.12)
Positive predictive value (%) 67.7 (58.2–76.9) 71.8 (61.4–80.2) 68.2 (60.9–75.4) 69.5 (62.1–76.0)
Negative predictive value (%) 78.4 (73.3–82.9) 80.2 (75.3–84.4) 97.6 (94.5–98.8) 97.6 (94.6–98.9)
Efficiency (%) 75.8 (70.1–80.7) 78.3 (73.9–82.2) 83.9 (80.7–87.5) 85.4 (81.5–88.6)
Pre-test probability (prevalence) (%) 32.6 (28.0–37.2) 31.5 (27.0–36.3) 33.0 (28.5–38.3) 31.5 (27.0–36.3)
Pre-test odds 0.5 (0.4–0.6) 0.5 (0.4–0.6) 0.5 (0.4–0.6) 0.5 (0.4–0.6)
Post-test odds 2.1 (1.2–3.4) 2.5 (1.4–4.8) 2.1 (1.5–3.7) 2.1 (1.5–3.6)
Post-test probability (%) 67.7 (57.9–76.8) 71.8 (57.4–82.8) 68.2 (58.0–67.3) 69.5 (58.8–78.5)
Number needed to diagnose (NND) 2.6 (3.8–2.1) 2.4 (3.5–1.9) 1.5 (1.5–1.2) 1.5 (1.5–1.2)
The analysis was performed for MS patients versus non-MS patients; data are reported with their 95%
confidence intervals.
3.3. Confounding Effects of Blood–Brain Barrier Permeability
The calculation of IgG and K indexes was based on an equivalent linear relationship between
albumin and IgG or KFLC, irrespective of the size differences of these molecules: albumin was 69 KDa,
IgG was 155 Kda, and KFLC was 22 KDa. For this reason, IgG loc and K loc were also calculated
using the Reiber formula that employs a hyperbolic relationship to correct for the size and repeated
analysis. The new parameters did not exhibit a better ROC curve for OB (IgG loc vs. IgG index AUC:
0.789 vs. 0.778; K loc vs. K index AUC: 0.978 vs. 0.981) or MS diagnosis (IgG loc vs. IgG index AUC:
0.801 vs. 0.789; K loc vs. K index AUC: 0.921 vs. 0.949). No significant differences were observed
according to the other performance parameters (Tables 2 and 3; supplementary material Figures S1
and S2).
4. Discussion
This study extends our previous analysis [8] on a larger cohort of patients and compares the
diagnostic performances of K and IgG indexes in detecting intrathecal synthesis and diagnosing MS.
It is widely accepted that the intrathecal synthesis of IgG is mirrored by the detection of OB
bands in CSF (exclusively in CSF than in serum), as analyzed by IEF followed by immunoblotting [16].
These qualitative findings are generally associated with a positive IgG index (above 0.7) and a positive
K index (above 5 in ourlaboratory setting) [8]. Since IEF for OB detection is the gold standard approach
in MS diagnosis, this study compared the ability of IgG and K indexes to detect OB and diagnose MS.
Despite the two markers correlating in both MS and non-MS patients, they showed different
diagnostic performances according to ROC analyses. In fact, the K index displayed better AUC values,
not only in predicting OB but also in diagnosing MS. Consequently, the performances of a sequential
test to detect intrathecal synthesis in MS was evaluated using a quantitative marker, followed by IEF
when elevated. The K index showed higher sensitivities in predicting OB and diagnosing MS. The K
index identified 96.1% of the MS patients whereas the IgG index only identified 59.1%. Specificity was
comparable for the two indexes. It was concluded that the K index was more efficient than the IgG
(Link) index as a quantitative test for intrathecal synthesis.
Secondly, the ability of the IgG and K indexes to discriminate ID and NID patients were compared.
The IgG index was not able to differentiate the two conditions, whereas the K index was elevated
in 33.3% ID and 7.8% NID patients. Moreover, OB were detectable in 29.9% of ID and 6.4% of NID
patients; in these groups, cases with types 2 or 3 IEF also had an elevated KFLC index (data not shown).
Thus, it can be concluded that the K index may help to differentiate ID from NID patients better than
the IgG index.
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Finally, this study was unable to demonstrate that the correction of the IgG or K indexes according
to Reiber’s formula may ameliorate the diagnostic power, which supports the value of the method
used in CSF analysis.
5. Conclusions
These results confirmed our previous proposal to use the K index as a highly sensitive and easy to
detect first-line marker in CSF analysis for intrathecal synthesis. If the K index is elevated, this first
analysis should be followed by IEF. By contrast, the IgG index should not be chosen for this role since
it showed lower diagnostic performances. This sequential testing may be an optimal procedure for
diagnosing MS with accurate performance and low cost. Of note, this sequential testing is being used
in our clinical practice according to recent evidence [17–19]
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/4/446/s1,
Figure S1: KFLC loc and IgG loc in MS (group 1), ID (group 2) and NID (group 3) patients; Figure S2: Correlations
between KFLC index, IgG index, KFLC loc and IgG loc in patients with multiple sclerosis; Table S1: Correlations
between IgG index and KFLC index among patients with multiple sclerosis (MS), inflammatory diseases (ID) and
non-inflammatory diseases (NID).
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